Comparison between Quest Laboratories IPO and Vilas Transcore IPO.
Quest Laboratories IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Vilas Transcore IPO is a SME Bookbuilding proposed to list at NSE SME.
| Quest Laboratories IPO | Vilas Transcore IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Shreni Shares Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Rikhav Securities Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Quest Laboratories IPO is up to ₹40.95 Cr whereas the issue size of the Vilas Transcore IPO is up to ₹90.46 Cr. The final issue price of Quest Laboratories IPO is ₹97.00 per share and of Vilas Transcore IPO is ₹147.00 per share.
| Quest Laboratories IPO | Vilas Transcore IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹93.00 per share | ₹139.00 per share |
| Issue Price (Upper) | ₹97.00 per share | ₹147.00 per share |
| Issue Price (Final) | ₹97.00 per share | ₹147.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1000 shares |
| Fresh Issue Size | 42,21,600 shares | 61,54,000 shares |
| Fresh Issue Size (Amount) | up to ₹40.95 Cr | up to ₹90.46 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 42,21,600 shares | 61,54,000 shares |
| Issue Size Total (Amount) | up to ₹40.95 Cr | up to ₹90.46 Cr |
Quest Laboratories IPO opens on May 15, 2024, while Vilas Transcore IPO opens on May 27, 2024. The closing date of Quest Laboratories IPO and Vilas Transcore IPO is May 17, 2024, and May 29, 2024, respectively.
| Quest Laboratories IPO | Vilas Transcore IPO | |
|---|---|---|
| Anchor Bid Date | May 14, 2024 | May 24, 2024 |
| Issue Open | May 15, 2024 | May 27, 2024 |
| Issue Close | May 17, 2024 | May 29, 2024 |
| Basis Of Allotment (Tentative) | May 21, 2024 | May 30, 2024 |
| Initiation of Refunds (Tentative) | May 22, 2024 | May 31, 2024 |
| Credit of Share (Tentative) | May 22, 2024 | May 31, 2024 |
| Listing date (Tentative) | May 23, 2024 | Jun 03, 2024 |
| Anchor Lockin End date 1 | Jun 20, 2024 | Jun 29, 2024 |
| Anchor Lockin End date 2 | Aug 19, 2024 | Aug 28, 2024 |
Quest Laboratories IPO P/E ratio is 23.03, as compared to Vilas Transcore IPO P/E ratio of 13.12.
| Quest Laboratories IPO | Vilas Transcore IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 90.36 | 99.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 65.82 | 73.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 23.03 | 13.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹158.96 Cr. | ₹359.86 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 34.03% | 13.03% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 41.86% | 16.10% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.20 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.21 | ₹11.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 34.03% | 12.24% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Quest Laboratories IPO Retail Individual Investors (RII) are offered 14,98,800 shares while in Vilas Transcore IPO retail investors are offered 14,98,800 shares. Qualified Institutional Buyers (QIB) are offered 8,31,600 shares in Quest Laboratories IPO and 12,31,000 shares in Vilas Transcore IPO.
| Quest Laboratories IPO | Vilas Transcore IPO | |
|---|---|---|
| Anchor Investor Reservation | 12,36,000 shares | 18,45,000 shares |
| Market Maker Reservation | 2,28,000 shares | 3,26,000 shares |
| QIB | 8,31,600 shares | 12,31,000 shares |
| NII | 6,55,200 shares | 9,24,000 shares |
| RII | 14,98,800 shares | 21,54,000 shares |
| Employee | ||
| Others | ||
| Total | 42,21,600 shares | 61,54,000 shares |
Quest Laboratories IPO subscribed 85.26x in total, whereas Vilas Transcore IPO subscribed 204.77x.
| Quest Laboratories IPO | Vilas Transcore IPO | |
|---|---|---|
| QIB (times) | 57.20x | 114.64x |
| NII (times) | 184.10x | 449.21x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 57.63x | 151.42x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 85.26x | 204.77x |
